AstraZeneca wins FDA breakthrough status for key cancer drug

LONDON (Reuters) - The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca's biggest new drug hope ‍durvalumab as a treatment in bladder cancer, the drugmaker said on Wednesday.

http://ift.tt/1KVP68Y

from Reuters: Health News
via animenewspro